Non steroidal anti-inflammatory drug-induced injury prevention and curatives strategies;Les complications digestives et extra-digestives des anti-inflammatoires non steroidiens strategies preventives et curatives

Revue Medicale de Bruxelles

Volumn 18, Issue 2, 1997, Pages 52-58

  Sternon, J ^a,c   Adler, M ^b  

^a Service de Médecine Interne Hoptial Erasme   (Belgium)

^b Service de Gastro Entérologie Hoptial Erasme   (Belgium)

^c CUMG   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMOXICILLIN; AURANOFIN; CHLOROQUINE; CLARITHROMYCIN; CORTICOSTEROID; HYDROXYCHLOROQUINE; IBUPROFEN; LYSOMUCIL; MELOXICAM; MESALAZINE; METHOTREXATE; MISOPROSTOL; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PIROXICAM; PROTON PUMP INHIBITOR; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG;

DIGESTIVE SYSTEM ULCER; DRUG CHOICE; GASTROINTESTINAL TOXICITY; HELICOBACTER PYLORI; HUMAN; PRESCRIPTION; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR;

EID: 0030976551     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Kurata JH, Abbey DE : The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations. J Clin Gastroenterol 12 : 260-266, 1990
2. Insel PA Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout In The Pharmacological Basis of Therapeutics. Edited by McGraw-Hill, New York, 1996, pp 622-624
3. Bordat IT, Koff RS : NSAIDs - A profile of adverse effects - Hanley and Belfuo, Inc Philadelphia 1992
4. Somerville K, Faulkner G, Langman MJS Risk factors for non-steroidal anti-inflammatory drug-associated upper gastrointestinal bleeding. Eur J Gastroenterol Hepatol 4 : 645-649, 1992
5. Acetaminophen, NSAIDs and alcohol Med Letter 38 : 55-56, 1996
6. Brooks PM, Day RO : Nonsteroidal antiinflammatory drugs Differences and similarities. N Engl J Med 324 : 1716-1725, 1991
7. Bateman DN : NSAIDs : time to re-evaluate gut toxicity Lancet 343 . 1051-1052, 1994
8. Langman MSJ, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RFA, Murphy M, Vessey MP, Colin-Jones DG : Risks of bleeding peptic ulcer associated with individual non-steroidal antiinflammatory drugs Lancet 343 : 1075-1078, 1994
9. Aslanian R, Carrurhers NI, Kaminski JJ : Cyclooxygenase-2 a novel target for therapeutic intervention. Exp Opin Invest Drugs 3 : 1323-1325, 1994
10. Vane J . Towards a better aspirin. Nature 367 : 215-216, 1994
11. Rational use of NSAIDs for musculoskeletal disorders Drug Ther Bull 32 . 91-95, 1994
12. Stucki G, Johannesson M, Liang MH : Is misoprostol cost-effective in the prevention of nonsteroidal anti-inflammatory drug-induced gastropathy in patients with chronic arthritis ? Arch Intern Med 154 : 2020-2025, 1994
13. Walt RP : Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration N Engl J Med 327 : 1575-1580, 1992
14. Sorokin R, Ward SB : Joint pain. Med Clin North Am 79 : 247-260
15. Levine JS : Misoprostol and nonsteroidal anti-inflammatory drugs : A tale of effects, outcomes, and costs (editorial) Ann Intern Med 123 : 309-310, 1995
16. Silverstein FE : Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non-steroidal anti-inflammatory drugs : a randomized, double-blind, placebo-controlled trial Ann Intern Med 123 : 241-249, 1995
17. Assessing the benefits of misoprostol for NSAID users. Hosp Pract 15 . 23-24, 1995
18. Fenn GC : Controversies in NSAID-induced gastro-duodenal damage : do they matter ? Aliment Pharmacol Ther 103 : 15-26, 1994
19. Bardhan KD, Bjarnason I, Scott DL : The prevention and healing of acute non-steroidal anti-inflammatory drug associated gastroduodenal mucosal damage by misoprostol. Br J Rheumatol 32 : 990-995, 1993
20. Arnett FC, Edworthy SM, Bloch DA, McShane J, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Finals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 : 315-324, 1988
21. Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, Kohler JA, Furst DE : Low dose long-term corticosteroid therapy in rheumatoid arthritis : an analysis of serious adverse events. Am J Med 96 : 115-123, 1994
22. O'Dell JR, Haire CE, Erikson N, Drymalski W, Palmer W, Eckhoff PJ, Garwood V, Maloley P, Klassen LW, Wees S, Klein H, Moore GF : Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 334 : 1287-1291, 1996
23. Lee WM : Drug-induced hepatotoxicity. N Engl J Med 333 . 1118-1127, 1995
24. Kirwan JR : The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 333 : 142-146, 1995
25. March L, Irwig L, Schwarz J, Simpson J, Chock C, Brooks P : n Of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. BMJ 309 :1041-1046, 1994
26. Jonville-Béra AP, Autret E : Intoxications aiguës graves au paracétamol et salicylés. Rev Prat 44 : 1797-1801, 1994
27. Jick H, Wald Myers M, Dean AD : The risk of sulfasalazine-and mesalazine-associated blood disorders. Pharmacotherapy 15 : 176-181, 1995
28. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 272 : 65-69, 1994
29. Schubert TT, Bologna SD, Nensey Y, Schubert AB, Mascha EJ : Ulcer risk factors : interactions between Helicobacter pylori infection, nonsteroidal use, and age Am J Med 94 413-418, 1993
30. Kim JG, Graham DY : Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. The Misoprostol Study Group. Am J Gastroenterol 89 : 203-207, 1994
31. Taha AS, Sturrock RD, Russell RI : Mucosal erosions in long-term non-steroidal anti-inflammatory drug users : predisposition to ulceration and relation to Helicobacter pylori. Gut 36 : 334-336, 1995
32. Publig W, Wustinger C, Zandl C : Non-steroidal anti-inflammatory drugs (NSAID) gastrointestinal ulcers mainly in Helicobacter pylori carriers. Wien KlinWochenschr 106 . 276-279, 1994
33. Laine L : Helicobacter pylori, gastric ulcer, and agents noxious to the gastric mucosa. Gastroenterol Clin North Am 22 : 117-125, 1993
34. Henry DA, Ostapowicz G, Robertson J : Drugs : a cause of gastrointestinal disease. Baillière's Clin Gastroenterol 8 : 271-300, 1994
35. Hollander D . Gastro-intestinal complications of nonsteroidal antiinflammatory drugs : prophylactic and therapeutic strategies. Am J Med 96 : 274-281, 1994
36. Gargot D, Festin D : Les complications intestinales des antiinflammatoires non stéroidiens. Rev Prat 229 : 53-56, 1993
37. Kaye O, Beckers C, Malaise MG : Applications cliniques nouvelles du méthotrexate en rhumatologie. Méd Hyg 52 : 1665-1670, 1994
38. Weinblatt ME . Methotrexate for chronic diseases in adults. N Engl J Med 332 : 330-31, 1995
39. Blackburn WD : Management of osteoarthritis and rheumatoid arthritis prospects and possibilities. Am J Med 100(suppl 2A) : 24S-30S, 1996
40. Amor B : Comment je traite la spondylarthrite ankylosante. Rev Prat - Méd Gén - 319 : 11-12, 1995
41. Harley JB, Hal Scofield R : The spectrum of ankylosing spondylitis Hosp Pract 15 :37-46, 1995
42. Slow-acting antirheumatic drugs. Drug Ther Bull 31 : 17-20, 1993
43. Drugs for rheumatoid arthritis. Med Lett 36 : 101-106, 1994